跳至主要内容
临床试验/ACTRN12621000021875
ACTRN12621000021875已完成未知

How does Flash Glucose Monitoring affect Blood Glucose Levels of Indigenous Australians with type 2 diabetes?- A Pilot Study.

niversity of Melbourne0 个研究点目标入组 40 人开始时间: 2021年1月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Indigenous Australians with type 2 diabetes and HbA1c greater than or equal to 7.0% (53mmol/L) AND one of the following:
  • -Injectable therapy (including insulin) ± oral hypoglycaemic agent, or
  • -GLP-1 analogue ± oral hypoglycaemia agent, or
  • -GLP-1 analogue and insulin ± oral hypoglycaemic agent

排除标准

  • Any of the following:
  • -Age < 18 years
  • -Type 1 diabetes mellitus
  • -Active illicit drug use or heavy alcohol use (> 4 standard drinks/day)
  • -Active malignancy
  • -Known allergy to medical-grade adhesives
  • -On varying doses of corticosteroid therapy
  • -Using amphetamines, anabolic or weight-reducing medications
  • -Pregnancy or actively planning pregnancy
  • -eGFR<15ml/min/1.732 or erythropoiesis stimulating agents or end-stage kidney disease
  • -Haemoglobinopathies.

研究者

发起方
niversity of Melbourne

相似试验